Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SGLT2 Inhibitors in Geographic Atrophy — Stella

Home/Retinal Degeneration/SGLT2 Inhibitors in Geographic Atrophy

View on ClinicalTrials.gov

Recruiting

Back to Retinal Degeneration trials

SGLT2 Inhibitors in Geographic Atrophy

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Washington University, St Louis, Missouri

Key details

Phase

Safety & dosing

Sponsor

Washington University School of Medicine

Enrollment target

~70 participants

Started

December 2025

Primary completion

December 2027

Age range

50 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.